BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11860293)

  • 1. Staining of sentinel node reticulum cells with cytokeratin antibody AE3.
    Yeh IT; Miller AR
    Arch Pathol Lab Med; 2002 Mar; 126(3):248-9. PubMed ID: 11860293
    [No Abstract]   [Full Text] [Related]  

  • 2. Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma.
    Xu X; Roberts SA; Pasha TL; Zhang PJ
    Arch Pathol Lab Med; 2000 Sep; 124(9):1310-3. PubMed ID: 10975928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Note of Caution: Variable Cytokeratin Staining in Sentinel Node Metastases.
    Zeng J; Alexander MA; Nimeh D; Darvishian F
    Int J Surg Pathol; 2015 Oct; 23(7):549-52. PubMed ID: 26215220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Another variable in lymph node biopsy.
    Rogers LW; Ries SG
    Am J Clin Pathol; 2000 Aug; 114(2):293-5. PubMed ID: 10941348
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
    Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
    Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up.
    Cserni G
    J Clin Pathol; 1999 Dec; 52(12):922-4. PubMed ID: 10711258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast and sensitive immunodetection of carcinoma cells in sentinel nodes.
    Karsten U; Stosiek P
    Virchows Arch; 2002 Mar; 440(3):325-9. PubMed ID: 11889605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of axillary sentinel lymph node biopsy by immunohistochemistry and multilevel sectioning in patients with breast carcinoma.
    Liu LH; Siziopikou KP; Gabram S; McClatchey KD
    Arch Pathol Lab Med; 2000 Nov; 124(11):1670-3. PubMed ID: 11079022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast carcinoma associated with necrotic granulomas in axillary lymph nodes.
    Sethi S; Carter D
    Ann Diagn Pathol; 1998 Dec; 2(6):370-6. PubMed ID: 9930574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
    El-Tamer M; Chun J; Gill M; Bassi D; Lee S; Hibshoosh H; Mansukhani M
    Ann Surg Oncol; 2005 Mar; 12(3):254-9. PubMed ID: 15827818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer.
    Mullenix PS; Brown TA; Meyers MO; Giles LR; Sigurdson ER; Boraas MC; Hoffman JP; Eisenberg BL; Torosian MH
    Am J Surg; 2005 May; 189(5):606-9; discussion 609. PubMed ID: 15862505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign transport of breast epithelium?
    Turner RR
    Am J Clin Pathol; 2000 Aug; 114(2):292-3, author reply 294-5. PubMed ID: 10941347
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of cancer metastases in regional lymph nodes: comparative histological and immunohistological investigations with the broad-range anticytokeratin monoclonal antibody A45-B/B3.
    Stosiek P; Kasper M; Karsten U; Goertchen R
    Neoplasma; 1991; 38(1):43-7. PubMed ID: 1707143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign Müllerian inclusions coexisting with breast metastatic carcinoma in an axillary lymph node.
    Piana S; Asioli S; Cavazza A
    Virchows Arch; 2005 Apr; 446(4):467-9. PubMed ID: 15785927
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraoperative detection of lymph node micrometastasis with flow cytometry in non-small cell lung cancer.
    Ito M; Minamiya Y; Kawai H; Saito S; Saito H; Imai K; Ogawa J
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):753-8. PubMed ID: 16153924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical demonstration of cytokeratin is useful for detecting micrometastatic foci from gallbladder carcinoma in regional lymph nodes.
    Tajima Y; Tomioka T; Ikematsu Y; Ichinose K; Inoue K; Kanematsu T
    Jpn J Clin Oncol; 1999 Sep; 29(9):425-8. PubMed ID: 10563195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glandular structures in an intraoperative axillary sentinel lymph node biopsy: a diagnostic dilemma.
    Nga ME; Putti TC
    Histopathology; 2006 Mar; 48(4):475-7. PubMed ID: 16487377
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
    Greenson JK; Isenhart CE; Rice R; Mojzisik C; Houchens D; Martin EW
    Cancer; 1994 Feb; 73(3):563-9. PubMed ID: 7507795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of endoscopic mucosal resection and nodal micrometastasis in pN0 submucosal gastric cancer.
    Endo K; Kohnoe S; Okamura T; Haraguchi M; Nishiyama K; Toh Y; Baba H; Maehara Y
    Oncol Rep; 2005 Jun; 13(6):1059-63. PubMed ID: 15870921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.